Researchers from Duke-NUS Medical School and Monash University have uncovered the mechanism behind microglial phagocytosis of amyloid proteins, one of the root causes of Alzheimer’s disease. With...
Eisai Co., Ltd. and Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for lecanemab (BAN2401), an investigational anti-amyloid beta...
As Singapore confronts an ageing population, diseases associated with the ageing process are rising to the fore. In this article, we clear up certain misconceptions and impart some basic knowledge on...
